Rowell Power

Biography

 r was Vice President and Head of PharmaTherapeutics Precision Medicine at Pfizer Global Research and Development in New London, CT, where he led a diverse group providing genomics, genetics and imaging expertise to projects across Cardiovascular, Neurosciences and Pain therapeutic areas, supporting novel target identification, biomarker development and precision medicine strategies for early stage clinical programs. Dr. Power led major external partnerships at Pfizer including Yale/Pfizer Bioimaging Alliance and Pfizer/NIH/NCATS’ New Therapeutic Uses Initiative, and his  group developed and delivered successful collaborations with major academic institutions including University of Cambridge, Karolinska Institutet, University College London, and Washington University in St. Louis. During more than twenty years at Pfizer in both the UK and US, Dr. Power developed and led the implementation of strategic organizational changes for te

Research Interest

 r was Vice President and Head of PharmaTherapeutics Precision Medicine at Pfizer Global Research and Development in New London, CT, where he led a diverse group providing genomics, genetics and imaging expertise to projects across Cardiovascular, Neurosciences and Pain therapeutic areas, supporting novel target identification, biomarker development and precision medicine strategies for early stage clinical programs. Dr. Power led major external partnerships at Pfizer including Yale/Pfizer Bioimaging Alliance and Pfizer/NIH/NCATS’ New Therapeutic Uses Initiative, and his  group developed and delivered successful collaborations with major academic institutions including University of Cambridge, Karolinska Institutet, University College London, and Washington University in St. Louis. During more than twenty years at Pfizer in both the UK and US, Dr. Power developed and led the implementation of strategic organizational changes for te